Literature DB >> 15289932

The role of apolipoprotein E in lipid metabolism in the central nervous system.

X Han1.   

Abstract

The critical roles of apolipoprotein E (apoE) in regulating plasma lipid and lipoprotein levels have been extensively studied for over 2 decades. However, an understanding of the roles of apoE in the central nervous system (CNS) is less certain. This review will summarize the available experimental results on the role of apoE in CNS lipid homeostasis with respect to its modulation of sulfatide trafficking, alteration of CNS cholesterol homeostasis and apoE-induced changes in phospholipid molecular species in specialized subcellular membrane fractions. The results indicate that apoE mediates sulfatide trafficking and metabolism in the CNS. Moreover, although apoE does not affect the cholesterol mass content or the phospholipid mass levels and composition in the CNS as a whole, apoE modulates cholesterol and phospholipid homeostasis in selective subcellular membrane compartments. Through elucidating the roles of apoE in CNS lipid metabolism, new insights into overall functions of apoE in neurobiology can be accrued ultimately, leading to an increased understanding of CNS lipid metabolism and the identification of novel therapeutic targets for CNS diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289932     DOI: 10.1007/s00018-004-4009-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

Review 1.  Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Neurometabolic roles of ApoE and Ldl-R in mouse brain.

Authors:  Jieun Lee; Joseph Choi; G William Wong; Michael J Wolfgang
Journal:  J Bioenerg Biomembr       Date:  2015-12-21       Impact factor: 2.945

Review 3.  Innate immune responses to HIV infection in the central nervous system.

Authors:  Rebeca Geffin; Micheline McCarthy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin.

Authors:  Hideki Hayashi; Robert B Campenot; Dennis E Vance; Jean E Vance
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

5.  Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1.

Authors:  Rao Fu; Nicole M Yanjanin; Matthew J Elrick; Christopher Ware; Andrew P Lieberman; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2012-09-28       Impact factor: 2.802

6.  HOTMAQ: A Multiplexed Absolute Quantification Method for Targeted Proteomics.

Authors:  Xiaofang Zhong; Qinying Yu; Fengfei Ma; Dustin C Frost; Lei Lu; Zhengwei Chen; Henrik Zetterberg; Cynthia Carlsson; Ozioma Okonkwo; Lingjun Li
Journal:  Anal Chem       Date:  2019-01-18       Impact factor: 6.986

7.  The association of apolipoprotein E gene polymorphisms with cerebral palsy in Chinese infants.

Authors:  Yiran Xu; Honglian Wang; Yanyan Sun; Qing Shang; Mingjie Chen; Tongchuan Li; Dengna Zhu; Lin He; Changlian Zhu; Qinghe Xing
Journal:  Mol Genet Genomics       Date:  2014-02-13       Impact factor: 3.291

Review 8.  Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics.

Authors:  Xianlin Han
Journal:  J Neurochem       Date:  2007-11       Impact factor: 5.372

9.  Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains.

Authors:  Maho Morishima-Kawashima; Xianlin Han; Yu Tanimura; Hiroki Hamanaka; Mariko Kobayashi; Takashi Sakurai; Minesuke Yokoyama; Koji Wada; Nobuyuki Nukina; Shinobu C Fujita; Yasuo Ihara
Journal:  J Neurochem       Date:  2007-05       Impact factor: 5.372

10.  GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with alpha-synuclein.

Authors:  Andrew O Koob; Amy D Paulino; Eliezer Masliah
Journal:  Neurosci Lett       Date:  2009-11-20       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.